Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-20-014776
Filing Date
2020-08-06
Accepted
2020-08-05 21:02:04
Documents
91
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 22477
2 ex99-1.htm EX-99.1 532459
3 ex99-2.htm EX-99.2 258780
4 ex99-3.htm EX-99.3 11679
5 ex99-4.htm EX-99.4 15234
6 form6-k_001.jpg GRAPHIC 11555
7 ex99-2_001.jpg GRAPHIC 6452
8 ex99-1_001.jpg GRAPHIC 11555
  Complete submission text file 0001493152-20-014776.txt   4779939

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE aezs-20200630.xml EX-101.INS 930241
10 XBRL SCHEMA FILE aezs-20200630.xsd EX-101.SCH 70579
11 XBRL CALCULATION FILE aezs-20200630_cal.xml EX-101.CAL 86451
12 XBRL DEFINITION FILE aezs-20200630_def.xml EX-101.DEF 201176
13 XBRL LABEL FILE aezs-20200630_lab.xml EX-101.LAB 389769
14 XBRL PRESENTATION FILE aezs-20200630_pre.xml EX-101.PRE 302582
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 201079484
SIC: 2834 Pharmaceutical Preparations